Unlocking Opportunities in the Cardiac Biomarkers Testing Market: Key Trends, Market Growth, and Forecast Insights
2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!
What Major Innovations Are Driving the Accelerated Growth of the Cardiac Biomarkers Testing Market?
The rise in cardiovascular diseases is anticipated to propel the growth of the cardiac biomarkers testing market. Cardiovascular diseases, essentially conditions impacting the heart or blood vessels, boost the need for cardiac biomarker tests, which help identify the levels of biomarkers and accurately gauge the severity and extent of a heart attack. Therefore, a surge in cardiovascular diseases will result in higher demand for cardiac biomarker testing solutions. For example, as per the American College of Cardiology, a US-based professional medical entity, there is a projected substantial increase in the rates of cardiovascular risk factors and diseases in the United States by 2060. Consequently, the growing prevalence of cardiovascular diseases is fuelling the expansion of the cardiac biomarkers testing market.
Get Your Free Sample Report Now – Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9436&type=smp
#What is the Anticipated CAGR of theCardiac Biomarkers Testing Market, and What Factors Will Drive It?
There has been a swift expansion in the size of the cardiac biomarkers testing market in the past few years. The market is projected to scale up from $13.48 billion in 2024 to $15.09 billion in 2025, showing a compound annual growth rate (CAGR) of 12.0%. Factors contributing to the growth during the historical period include rising cases of cardiovascular diseases, an aging population, knowledge and education drives, government plans and healthcare policies, and higher healthcare spending.
The market size for cardiac biomarkers testing is anticipated to experience substantial growth in the coming years, reaching a value of $23.75 billion in 2029 with a 12.0% compound annual growth rate (CAGR). This expected increase during the forecast period can be linked to various factors such as the emergence of personalized medicine, the escalating worldwide cardiovascular disease burden, the incorporation of artificial intelligence (AI) in diagnostics, proliferation of point-of-care testing and a heightened focus on early detection of diseases. Noticeable trends in this duration consist of progressive technological enhancements, improvements in AI-supported diagnostics, enlargement of point-of-care testing (POCT), burgeoning multiplexing capabilities, as well as biomarker identification and substantiation.
You can Directly Purchase the Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9436
What Are the Most Significant Market Trends Transforming theCardiac Biomarkers Testing Market?
Leading firms in the cardiac biomarker testing industry are forging strategic alliances for advancing technology for early detection of heart conditions, thus improving patient results. Such partnerships in the cardiac biomarker testing sphere promote inter-corporate cooperation, paving the way for ground-breaking diagnostics, widening market accessibility, and hastening the provision of advanced testing options for improved heart care. For example, in September 2024, MediBuddy, a health tech firm based in India that offers a wide-ranging platform for telemedicine services, health administration, and insurance support, formed a partnership with Philips, a conglomerate company based in the Netherlands. Through this alliance, the objective is to boost cardiac care in India by integrating Philips’ HeartPrint technology, enabling ongoing monitoring and risk evaluation for heart health. This proactive strategy equips users with advanced resources on the MediBuddy platform, fostering active heart health management and better results.
What Are the Top Market Players Propelling the Growth of theCardiac Biomarkers Testing Industry?
Major companies operating in the cardiac biomarkers testing market include Abbott Laboratories, Bio-Rad Laboratories Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd., Siemens Healthineers AG, Thermo Fisher Scientific Inc., Biomérieux SA, Becton Dickinson and Company, Randox Laboratories Ltd., Enzo Biochem Inc., Creative Diagnostics Inc., Merck Co. & KGaA, Beckman Coulter Inc., QIAGEN N.V., PerkinElmer Inc., Tosoh Corporation, Eurolyser Diagnostica GmbH, Cortez Diagnostics Inc., DIALAB GmbH, CardioGenics Holdings Inc., Lepu Medical Technology (Beijing) Co. Ltd., Biosynex SA, Charles River Laboratories, Quidel Corporation, Life Diagnostics, Trinity Biotech plc, Guangzhou Wondfo Biotech Co. Ltd., Nova Biomedical Corp., Ortho Clinical Diagnostics Inc., Sekisui Diagnostics Inc., Abcam plc, Bio-Techne Corporation
Order Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/cardiac-biomarkers-testing-global-market-report
Which Primary Segments of the Cardiac Biomarkers Testing Market Are Driving Growth and Industry Transformations?
The cardiac biomarkers testing market covered in this report is segmented –
1) By Biomarkers Type: Creatine Kinase (CK-MB), Troponins, Myoglobin, Natriuretic Peptides (BNP And NT-proBNP), Ischemia Modified Albumin (IMA), Other Biomarkers Types
2) By Application: Congestive Heart Failure, Acute Coronary Syndrome, Myocardial Infarction, Atherosclerosis, Other Applications
3) By End-User: Hospitals, Specialty Clinics
Subsegments:
1) By Creatine Kinase (CK-MB): Total CK-MB, CK-MB Mass
2) By Troponins: Cardiac Troponin I (cTnI), Cardiac Troponin T (cTnT)
3) By Myoglobin: Total Myoglobin
4) By Natriuretic Peptides: B-Type Natriuretic Peptide (BNP), N-Terminal Pro B-Type Natriuretic Peptide (NT-ProBNP)
5) By Ischemia Modified Albumin (IMA): IMA Levels
6) By Other Biomarkers Types: C-Reactive Protein (CRP), Heart-Type Fatty Acid-Binding Protein (H-FABP), Soluble ST2
Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=9436&type=smpGlobal Cardiac Biomarkers Testing Market, Global Cardiac Biomarkers Testing Market Report, Global Cardiac Biomarkers Testing Market Trends, Global Cardiac Biomarkers Testing Market Size
Browse Through More Reports Similar to the Gobal Cardiac Biomarkers Testing Maret 2025, By The Business Research Company:
Interventional Cardiology Devices And Equipment Global Market Report 2024
Cardiovascular Monitoring And Diagnostic Devices And Equipment Global Market Report 2024
Cardiovascular Medical Lasers Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/cardiovascular-medical-lasers-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
